Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript

X4 Pharmaceuticals, Inc (XFOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/22/2023 4 WYZGA MICHAEL S (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Bought 25,000 shares @ $1.195, valued at $29.9k
08/16/2023 3 Arbet-Engels Christophe (Chief Medical Officer) has filed a Form 3 on X4 Pharmaceuticals, Inc
08/11/2023 4 Stewart Murray (Interim Chief Medical Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 269,893 shares @ $0
Sold 130,056 shares @ $1.06, valued at $137.9k
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from"
08/03/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
07/05/2023 4 DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 464 shares @ $1.89, valued at $877
07/05/2023 4 Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 2,641 shares @ $1.89, valued at $5k
06/30/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 857 shares @ $2.23, valued at $1.9k
06/16/2023 4 Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 5,417 shares @ $2.22, valued at $12k
06/16/2023 4 Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 6,724 shares @ $2.23, valued at $15k
06/16/2023 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.2% stake in X4 PHARMACEUTICALS, INC.
06/09/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/01/2023 D Form D - Notice of Exempt Offering of Securities:
06/01/2023 8-K Regulation FD Disclosure  Interactive Data
05/31/2023 4 Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 6,292 shares @ $1.95, valued at $12.3k
05/31/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 SC 13D/A Growth Equity Opportunities 18 VGE, LLC reports a 10% stake in X4 Pharmaceuticals, Inc.
05/16/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events ...
Docs: "X4 PHARMACEUTICALS, INC. FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK",
"SECURITIES PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market",
"X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate, Severity, and Duration of Infections vs. Placebo in Participants Diagnosed with WHIM Syndrome",
"01 02 03 04 05 06"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
05/04/2023 8-K Quarterly results
05/04/2023 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports First-Quarter 2023 Financial Results and Provides Corporate Update"
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/25/2023 ARS Form ARS - Annual Report to Security Holders:
04/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/25/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/21/2023 8-K Regulation FD Disclosure  Interactive Data
03/21/2023 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update"
03/13/2023 4 DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 18,192 shares @ $0.84, valued at $15.3k
03/13/2023 4 Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Sold 52,500 shares @ $0.84, valued at $44.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy